Cargando…

Peyronie's Disease Treated with Oral Weekly Dexamethasone and Continuous Low-dose Cyclophosphamide

Detalles Bibliográficos
Autores principales:	Gupta, Ramji, Gupta, Sachi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	E-Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037975/ https://www.ncbi.nlm.nih.gov/pubmed/24891685 http://dx.doi.org/10.4103/0019-5154.131463

Ejemplares similares

DEXAMETHASONE–CYCLOPHOSPHAMIDE PULSE THERAPY IN PROGRESSIVE SYSTEMIC SCLEROSIS
por: Viswanath, Vishalakshi, et al.
Publicado: (2010)

Reduced Weekly Subcutaneous Doses of Bortezomib in Combination with Cyclophosphamide and Dexamethasone for Newly Diagnosed Multiple Myeloma
por: Ashrafi, Farzaneh, et al.
Publicado: (2020)

Structured Self-Rated Response to Iontophoresis with Verapamil and Dexamethasone in Peyronie's Disease
por: Kokab, Abas, et al.
Publicado: (2014)

Oral vinorelbine and continuous low doses of cyclophosphamide in pediatric rhabdomyosarcoma: a real-world study
por: Lan, Yingxia, et al.
Publicado: (2023)

Multiple Infantile Hemangiomas Treated Successfully with Oral Propranolol
por: Purkait, Radheshyam, et al.
Publicado: (2016)

Phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced breast cancer
por: Cousin, Sophie, et al.
Publicado: (2022)

Can Darrier Disease be Localized Bullous??!!
por: Raval, Ranjan C, et al.
Publicado: (2013)

Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma
por: Andersen, Kristian T., et al.
Publicado: (2020)

A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1)
por: Chen, Yunxin, et al.
Publicado: (2021)

Oral dexamethasone for COVID-19 patients at the initial recognition of hypoxia: Can an early dose herald a better outcome?
por: Lo, Ching-Lung, et al.
Publicado: (2022)

Low dose anti-thymocyte globulin with low dose posttransplant cyclophosphamide (low dose ATG/PTCy) can reduce the risk of graft-versus-host disease as compared with standard-dose anti-thymocyte globulin in haploidentical peripheral hematopoietic stem cell transplantation combined with unrelated cord blood
por: Xu, Xiaoqian, et al.
Publicado: (2020)

Addition of cyclophosphamide and higher doses of dexamethasone do not improve outcomes of patients with AL amyloidosis treated with bortezomib
por: Kastritis, E, et al.
Publicado: (2017)

Randomized phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced soft-tissue sarcoma
por: Toulmonde, Maud, et al.
Publicado: (2022)

Simple Scoring System for Oral Pemphigus Vulgaris
por: Thorakkal, Shamim
Publicado: (2013)

Multiple Fungal Infection in a Patient on Chronic Low Dose Corticotherapy
por: Yamazato, Shiho, et al.
Publicado: (2014)

Oral therapy for Peyronie’s disease, does it work?
por: Barrett-Harlow, Brittani, et al.
Publicado: (2016)

Potential Cost Savings With Low-Dose Abiraterone in the United States
por: Premnath, Naveen, et al.
Publicado: (2020)

Inflammatory Linear Verrucous Epidermal Nevus with Psoriasiform Histology
por: Agarwal, Uma Shankar, et al.
Publicado: (2014)

Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
por: Khan, O A, et al.
Publicado: (2011)

Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
por: Khan, O A, et al.
Publicado: (2011)

Methotrexate-Induced Toxic Epidermal Necrolysis in a Child
por: Gogia, Ajay, et al.
Publicado: (2013)

Topical Adapalene in the Treatment of Plantar Warts; Randomized Comparative Open Trial in Comparison with Cryo-Therapy
por: Gupta, Ramji, et al.
Publicado: (2015)

Fixed Drug Eruption Due to Ornidazole
por: Gupta, Ramji
Publicado: (2014)

A Case of Multiple Facial Clear Cell Acanthomas Successfully Treated by Cryotherapy
por: Hatakeyama, Mayumi, et al.
Publicado: (2013)

Steroid-Resistant Localized Lymphomatoid Papulosis Treated with Local Bath-PUVA Therapy
por: Errichetti, Enzo, et al.
Publicado: (2013)

Two Weeks of “COVID-19” Search on PubMed.gov
por: Liu, Antonio
Publicado: (2020)

Epidural Extramedullary Plasmacytoma Successfully Treated with Surgical Excision and Bortezomib, Cyclophosphamide and Dexamethasone
por: MARTIO, ARTUR EDUARDO, et al.
Publicado: (2023)

Low-Dose Oral Retinoid Combined with Topical Therapy Successfully Treats Punctate Palmoplantar Keratoderma Lesions Misdiagnosed as Corns: A Case Report
por: Jung, Joon Woo, et al.
Publicado: (2021)

Dexamethasone- cyclophosphamide pulse in collagen vascular diseases: An observation
por: Das, Sudip, et al.
Publicado: (2011)

Continuous Low-Dose Oral Chemotherapy in Recurrent and Persistent Carcinoma of Cervix Following Chemoradiation: A Comparative Study Between Prolonged Oral Cyclophosphamide and Oral Etoposide
por: Baruah, Upasana, et al.
Publicado: (2014)

Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial
por: Pannier, Diane, et al.
Publicado: (2018)

The pathophysiology of Peyronie’s disease
por: El-Sakka, Ahmed I., et al.
Publicado: (2013)

Peyronie’s disease: is it genetic or not?
por: Gabrielsen, J. Scott
Publicado: (2020)

Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice‐weekly carfilzomib (45 and 56 mg/m(2)) in combination with lenalidomide and dexamethasone
por: Korde, Neha, et al.
Publicado: (2021)

Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation
por: Crusoe, Edvan De Queiroz, et al.
Publicado: (2020)

Pembrolizumab combined with low-dose cyclophosphamide and intra-tumoral injection of the toll-like receptor 4 agonist G100 in patients with advanced pretreated soft tissue sarcoma: results from the PEMBROSARC basket study
por: Spalato-Ceruso, Mariella, et al.
Publicado: (2022)

Dexamethasone in community-acquired pneumonia
por: Lee, Nelson, et al.
Publicado: (2011)

Low-dose cyclophosphamide-induced acute hepatotoxicity
por: Subramaniam, S. Ravih, et al.
Publicado: (2013)

Low-Dose Cyclophosphamide Associated With Hyponatremia and Hepatotoxicity
por: DeChiara, James R, et al.
Publicado: (2023)

Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis
por: Brennan, Xavier, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_elb4ogq7fu0bdgpfmrq2mrqufk